GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Total Tax Payable

Shanghai Fosun Pharmaceutical (Group) Co (SHSE:600196) Total Tax Payable : ¥649 Mil (As of Mar. 2025)


View and export this data going back to 1998. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Total Tax Payable?

Shanghai Fosun Pharmaceutical (Group) Co's Total Tax Payable for the quarter that ended in Mar. 2025 was ¥649 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly Total Tax Payable increased from Sep. 2024 (¥537 Mil) to Dec. 2024 (¥561 Mil) and increased from Dec. 2024 (¥561 Mil) to Mar. 2025 (¥649 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual Total Tax Payable declined from Dec. 2022 (¥930 Mil) to Dec. 2023 (¥537 Mil) but then increased from Dec. 2023 (¥537 Mil) to Dec. 2024 (¥561 Mil).

Shanghai Fosun Pharmaceutical (Group) Co Total Tax Payable Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Total Tax Payable Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 564.73 727.59 929.84 536.97 560.74

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 529.60 520.97 537.02 560.74 649.02

Shanghai Fosun Pharmaceutical (Group) Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Shanghai Fosun Pharmaceutical (Group) Co Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) » Definitions » Total Tax Payable
Comparable Companies
SZSE:000999 SZSE:000963 SHSE:600085 SZSE:002001 SZSE:000423 SZSE:000661 SHSE:600079 SZSE:000513 SHSE:600518 SHSE:688192 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
SFOSF:USA 02196:Hong Kong 08HH:Germany
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Website
https://www.fosunpharma.com
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Executives
Yao Fang Director
Wu Yi Fang Director
Wen De Yong Directors, senior managers
Guan Xiao Hui Director
Wang Ke Xin Director
Bao Qin Gui senior management
Mei Jing Ping senior management
Li Sheng Li senior management
Feng Rong Li senior management
Wang Dong Hua senior management
Dong Xiao Xian senior management
Su Li senior management
Zhu Yue senior management
Chen Yu Qing senior management
Hu Hang senior management

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines